News

The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...
A decision is expected in the fourth quarter of 2025.
The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...
The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...
GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...
Cigna (CI) unveils ENGUIDE, a specialized GLP-1 pharmacy to be launched next month as demand for obesity drugs like Wegovy ...
CVS Caremark has selected Novo Nordisk’s Wegovy as the preferred GLP-1 medication for its largest commercial template formularies, effective July 1. In March, Novo Nordisk launched NovoCare Pharmacy ...
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic ...